Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zontron pharmaceuticals sdn. bhd. - calcium pantothenate; cyanocobalamin; pyridoxine hcl/vitamin b6; riboflavine; thiamine mononitrate; nicotinamide -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zontron pharmaceuticals sdn. bhd. - calcium pantothenate; thiamine mononitrate; nicotinamide; cyanocobalamin; pyridoxine hcl/vitamin b6; riboflavine -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn bhd - calcium carbonate; calcium pantothenate; magnesium hydroxide; potassium iodide; zinc chloride; ferrous fumarate; cyanocobalamin; pyridoxine hcl/vitamin b6; riboflavine; thiamine mononitrate; nicotinamide; vitamin d3 type-100; ascorbic acid, coated; copper sulfate; retinyl palmitate ( vitamin a ); manganese hypophosphite monohydrate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn bhd - ascorbic acid; biotin; calcium pantothenate; folic acid; cyanocobalamin; pyridoxine hcl/vitamin b6; riboflavine; thiamine mononitrate; nicotinamide -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbott laboratories (m) sdn. bhd. - zinc; pyridoxine hcl/vitamin b6; calcium pantothenate; riboflavine; thiamine mononitrate; cyanocobalamin; vitamin e acetate; ascorbic acid; folic acid; nicotinamide -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sdn. bhd. - calcium pantothenate; cyanocobalamin; riboflavine; nicotinamide; thiamine mononitrate; biotin; pyridoxine hcl/vitamin b6 -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hovid berhad - thiamine mononitrate; pyridoxine hcl/vitamin b6; cyanocobalamin; calcium pantothenate; riboflavine; nicotinamide -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

prime pharmaceutical sdn. bhd. - pyridoxine hcl/vitamin b6; niacinamide; calcium pantothenate; cyanocobalamin; riboflavine; folic acid; thiamine mononitrate -

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a c